Bright Health Group, Inc.
NYSE:BHG
16.35 (USD) • At close January 26, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 1,160.802 | 2,412.03 | 4,029.389 | 1,207.32 | 280.673 | 130.632 |
| Cost of Revenue
| 1,283.72 | 2,206.243 | 3,953.674 | 1,047.3 | 224.387 | 96.407 |
| Gross Profit
| -122.918 | 205.787 | 75.715 | 160.02 | 56.286 | 34.225 |
| Gross Profit Ratio
| -0.106 | 0.085 | 0.019 | 0.133 | 0.201 | 0.262 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 19.433 | 7.243 | 2.541 |
| General & Administrative Expenses
| 0 | 501.84 | 626.359 | 211.749 | 104.222 | 54.483 |
| Selling & Marketing Expenses
| 0 | 82.34 | 287.755 | 96.942 | 49.711 | 26.75 |
| SG&A
| 0 | 584.18 | 914.114 | 308.691 | 153.933 | 81.233 |
| Other Expenses
| 1,737.798 | 98.28 | 359.757 | 89.499 | 20.447 | 13.092 |
| Operating Expenses
| 1,737.798 | 682.46 | 1,273.871 | 417.623 | 181.623 | 96.866 |
| Operating Income
| -627.742 | -476.673 | -1,198.156 | -257.603 | -125.337 | -62.641 |
| Operating Income Ratio
| -0.541 | -0.198 | -0.297 | -0.213 | -0.447 | -0.48 |
| Total Other Income Expenses Net
| -1.428 | -157.612 | -6.73 | 8.468 | 8.35 | 3.51 |
| Income Before Tax
| -629.17 | -634.285 | -1,204.886 | -257.603 | -125.337 | -62.641 |
| Income Before Tax Ratio
| -0.542 | -0.263 | -0.299 | -0.213 | -0.447 | -0.48 |
| Income Tax Expense
| -1.428 | 3.68 | -26.521 | -9.161 | 8.35 | 3.51 |
| Net Income
| -1,200.599 | -637.965 | -1,178.365 | -248.442 | -133.687 | -62.641 |
| Net Income Ratio
| -1.034 | -0.264 | -0.292 | -0.206 | -0.476 | -0.48 |
| EPS
| -150.94 | -81.08 | -240.33 | -145.94 | -79.52 | -37.97 |
| EPS Diluted
| -150.94 | -81.08 | -240.33 | -145.94 | -79.52 | -37.97 |
| EBITDA
| -1,145.528 | -425.314 | -1,161.446 | -249.314 | -124.203 | -61.611 |
| EBITDA Ratio
| -0.987 | -0.176 | -0.288 | -0.207 | -0.443 | -0.472 |